Beranda › Penyakit Paru Interstisial › Pennsylvania › Pittsburgh
Uji klinis Penyakit Paru Interstisial di Pittsburgh, PA
5 studi untuk Penyakit Paru Interstisial mencari peserta di lokasi sekitar Pittsburgh (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Menerima pesertaFase 3
- University of Pittsburgh Medical Center, Pittsburgh
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Menerima pesertaFase 2
- UPMC Montefiore, Pittsburgh
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Menerima pesertaFase 2/3
- GSK Investigational Site, Pittsburgh
Dorothy P. and Richard P. Simmons Center for ILD Research Registry
Menerima pesertaStudi observasional
- Michelle F MacPherson, Pittsburgh
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Menerima pesertaFase 2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
Uji klinis Penyakit Paru Interstisial di kota lain
- New York City, NY18 studi
- Philadelphia, PA16 studi
- Los Angeles, CA14 studi
- Kansas City, KS13 studi
- Durham, NC13 studi
- Charleston, SC13 studi
- Chicago, IL12 studi
- Houston, TX12 studi
- Aurora, CO11 studi
- Ann Arbor, MI11 studi
- Phoenix, AZ9 studi
- Salt Lake City, UT9 studi
Studi lain di Pittsburgh
- Kanker Paru Non-Sel Kecil48 studi
- Kanker (semua jenis)41 studi
- Kanker Payudara39 studi
- Kanker Kolorektal32 studi
- Kanker Metastatik31 studi
- Melanoma31 studi
- Kanker Ovarium30 studi
- Kanker Endometrium23 studi
- Kanker Paru23 studi
- Kanker Prostat23 studi
- Stroke22 studi
- Karsinoma Sel Skuamosa Kepala dan Leher22 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.